A controlled comparison of amcinonide cream 0.1 percent and halcinonide cream 0.1 percent in the treatment of eczematous dermatitis

L. Guenther, Alvin Jr Solomon, J. J. Voorhees

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

A 2-week, double-blind clinical trial was conducted to compare the efficacy and cosmetic acceptability of amcinonide cream 0.1 percent and halcinonide cream 0.1 percent in the treatment of 29 patients with eczematous dermatitis. The dermatologic status of each patient was rated by improvement in clinical signs and symptoms, by the investigator's overall evaluation, and by two patient evaluations. Both medications produced statistically significant and equivalent improvement by Week 2. However, amcinonide was significantly favored in the efficacy evaluation of relief from burning/pain at Week 2 and in patient acceptability evaluations in regard to the absence of burning, stinging, and itching on application. The role of propylene glycol in the formulation of the halcinonide cream as a contributing cause of irritation is noted.

Original languageEnglish (US)
Pages (from-to)461-467
Number of pages7
JournalCutis
Volume28
Issue number4
StatePublished - 1981
Externally publishedYes

Fingerprint

Halcinonide
Eczema
Propylene Glycol
Therapeutics
Pruritus
Cosmetics
Signs and Symptoms
Research Personnel
Clinical Trials
Pain
amcinonide

ASJC Scopus subject areas

  • Dermatology
  • Immunology and Allergy

Cite this

A controlled comparison of amcinonide cream 0.1 percent and halcinonide cream 0.1 percent in the treatment of eczematous dermatitis. / Guenther, L.; Solomon, Alvin Jr; Voorhees, J. J.

In: Cutis, Vol. 28, No. 4, 1981, p. 461-467.

Research output: Contribution to journalArticle

Guenther, L. ; Solomon, Alvin Jr ; Voorhees, J. J. / A controlled comparison of amcinonide cream 0.1 percent and halcinonide cream 0.1 percent in the treatment of eczematous dermatitis. In: Cutis. 1981 ; Vol. 28, No. 4. pp. 461-467.
@article{337e26cb41fa4bcebbfd702e1e2873dd,
title = "A controlled comparison of amcinonide cream 0.1 percent and halcinonide cream 0.1 percent in the treatment of eczematous dermatitis",
abstract = "A 2-week, double-blind clinical trial was conducted to compare the efficacy and cosmetic acceptability of amcinonide cream 0.1 percent and halcinonide cream 0.1 percent in the treatment of 29 patients with eczematous dermatitis. The dermatologic status of each patient was rated by improvement in clinical signs and symptoms, by the investigator's overall evaluation, and by two patient evaluations. Both medications produced statistically significant and equivalent improvement by Week 2. However, amcinonide was significantly favored in the efficacy evaluation of relief from burning/pain at Week 2 and in patient acceptability evaluations in regard to the absence of burning, stinging, and itching on application. The role of propylene glycol in the formulation of the halcinonide cream as a contributing cause of irritation is noted.",
author = "L. Guenther and Solomon, {Alvin Jr} and Voorhees, {J. J.}",
year = "1981",
language = "English (US)",
volume = "28",
pages = "461--467",
journal = "Cutis",
issn = "0011-4162",
publisher = "Quadrant Healthcom Inc.",
number = "4",

}

TY - JOUR

T1 - A controlled comparison of amcinonide cream 0.1 percent and halcinonide cream 0.1 percent in the treatment of eczematous dermatitis

AU - Guenther, L.

AU - Solomon, Alvin Jr

AU - Voorhees, J. J.

PY - 1981

Y1 - 1981

N2 - A 2-week, double-blind clinical trial was conducted to compare the efficacy and cosmetic acceptability of amcinonide cream 0.1 percent and halcinonide cream 0.1 percent in the treatment of 29 patients with eczematous dermatitis. The dermatologic status of each patient was rated by improvement in clinical signs and symptoms, by the investigator's overall evaluation, and by two patient evaluations. Both medications produced statistically significant and equivalent improvement by Week 2. However, amcinonide was significantly favored in the efficacy evaluation of relief from burning/pain at Week 2 and in patient acceptability evaluations in regard to the absence of burning, stinging, and itching on application. The role of propylene glycol in the formulation of the halcinonide cream as a contributing cause of irritation is noted.

AB - A 2-week, double-blind clinical trial was conducted to compare the efficacy and cosmetic acceptability of amcinonide cream 0.1 percent and halcinonide cream 0.1 percent in the treatment of 29 patients with eczematous dermatitis. The dermatologic status of each patient was rated by improvement in clinical signs and symptoms, by the investigator's overall evaluation, and by two patient evaluations. Both medications produced statistically significant and equivalent improvement by Week 2. However, amcinonide was significantly favored in the efficacy evaluation of relief from burning/pain at Week 2 and in patient acceptability evaluations in regard to the absence of burning, stinging, and itching on application. The role of propylene glycol in the formulation of the halcinonide cream as a contributing cause of irritation is noted.

UR - http://www.scopus.com/inward/record.url?scp=0019836382&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019836382&partnerID=8YFLogxK

M3 - Article

VL - 28

SP - 461

EP - 467

JO - Cutis

JF - Cutis

SN - 0011-4162

IS - 4

ER -